Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Liu, J., Packer, M., Desai, A. S., … Solomon, S. D. (2021). Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial. European Journal of Heart Failure, 23(9), 1518–1524. https://doi.org/10.1002/ejhf.2259

Bhatt, Ankeet S., Muthiah Vaduganathan, Brian L. Claggett, Jiankang Liu, Milton Packer, Akshay S. Desai, Martin P. Lefkowitz, et al. “Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial.” European Journal of Heart Failure 23, no. 9 (September 2021): 1518–24. https://doi.org/10.1002/ejhf.2259.

Bhatt AS, Vaduganathan M, Claggett BL, Liu J, Packer M, Desai AS, et al. Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial. European Journal of Heart Failure. 2021 Sep;23(9):1518–24.

Bhatt, Ankeet S., et al. “Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial.” European Journal of Heart Failure, vol. 23, no. 9, Oxford University Press (OUP), Sept. 2021, pp. 1518–24. Crossref, doi:10.1002/ejhf.2259.

Bhatt AS, Vaduganathan M, Claggett BL, Liu J, Packer M, Desai AS, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Vardeny O, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial. European Journal of Heart Failure. Oxford University Press (OUP); 2021 Sep;23(9):1518–1524.